SavedAdd your journal

Journals / İstanbul Sabahattin Zaim Üniversitesi Fen Bilimleri Enstitüsü Dergisi / 2019 / Cilt: 1 - Sayı: 1

New diet approaches in irritable bowel syndrome

İrritable Bağırsak Sendromunda Güncel Diyet Yaklaşımları

Elif EDE
Havvanur YOLDAŞ İLKTAÇ
Pages
1–6
Publication Date
2019-03-13
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For this purpose, the efficacy of FODMAPs diet, vitamin D, prebiotic and probiotic supplements in IBS nutritional therapy was investigated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Irritable bowel syndrome (IBS) is a functional bowel disease characterized by a change in intestinal motility, the cause of which is unknown.
📊
Key Findings & Data:The incidence of IBS in societies varies between 10-25%.
💡
Conclusion & Impact:For this purpose, the efficacy of FODMAPs diet, vitamin D, prebiotic and probiotic supplements in IBS nutritional therapy was investigated.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Irritable Bağırsek Sendromu · Beslenme · FODMAPs

Abstract

Irritable bowel syndrome (IBS) is a functional bowel disease characterized by a change in intestinal motility, the cause of which is unknown. The incidence of IBS in societies varies between 10-25%. IBS, which is not a life-threatening disease, has many symptoms, such as abdominal pain or discomfort in the abdomen, diarrhea, constipation and bloating, which significantly affect the quality of life. Since IBS is idiopathic, treatment with IBS is designed to alleviate symptoms. All these symptoms, which greatly affect the quality of life, can be exacerbated or diminished depending on the individual's eating habits. In this review, it is aimed to provide an overview of nutritional therapy and current nutritional therapy approaches in irritable bowel syndrome. For this purpose, the efficacy of FODMAPs diet, vitamin D, prebiotic and probiotic supplements in IBS nutritional therapy was investigated.

Özet

İrritable bağırsak sendromu (İBS) nedeni bilinmeyen, bağırsak hareketlerinde değişiklik ile karakterize fonksiyonel bir bağırsak hastalığıdır. İBS’nin toplumlarda görülme sıklığı %10-25 arasında değişiklik göstermektedir. Hayatı tehdit edici bir hastalık olmayan İBS’nin hayat kalitesini önemli ölçüde etkileyen karın ağrısı veya karında rahatsızlık hissi, ishal, kabızlık ve şişkinlik gibi birçok semptomu bulunmaktadır. İBS’nin idiyopatik olması sebebiyle İBS tedavisi semptomları hafifletmeye yönelik olarak yapılmaktadır. Hayat kalitesini büyük ölçüde etkileyen tüm bu semptomlar bireyin beslenme alışkanlıklarına göre şiddetlenebilmekte veya hafifleyebilmektedir. Bu derlemede, irritable bağırsak sendromunda beslenme tedavisinin öneminin ve güncel beslenme tedavisi yaklaşımlarının ortaya konması amaçlanmaktadır. Bu amaçla İBS beslenme tedavisinde FODMAPs diyeti, D vitamini, prebiyotik ve probiyotik takviyelerinin etkinliği incelenmiştir.

🔖

Cite This Article

EDE, E., İLKTAÇ, H. Y. (2019). New diet approaches in irritable bowel syndrome. İstanbul Sabahattin Zaim Üniversitesi Fen Bilimleri Enstitüsü Dergisi, Cilt: 1 - Sayı: 1, 1–6. https://ajindex.com/articles/772086

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Abbasnezhad, A., Amani, R., Hajiani, E., Alavinejad, P., Cheraghian, B., Ghadiri, A. (2016). Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrom patients: a randomized double-blind clinical trial. Journal Of Neurogastroenterology And Motılıty 28 (10):1533–1544, doi: 10.1111/nmo.12851. Barrett, J.S. (2013). Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms. Nutrıtıon In Clınıcal Practıce. 28(3):300-6, doi: 10.1177/0884533613485790. Baştürk, A., Artan, R., Yılmaz, A. (2016). Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial. The Turkısh Journal Of Gastroenterology, 27: 439-43, doi: 10.5152/tjg.2016.16301. Can, G., Yılmaz, B. (2015). İrritabl Barsak Sendromunun Tanı ve Tedavisinde Yaklaşımlar, Güncel Gastroenteroloji. 19(3):171-181, doi: 10.5152/tjg.2016.16301. Canavan, C., West, J., Card, T. (2014). The epidemiology of irritable bowel syndrome, Clınıcal Epıdemıology. 2014(6):71–80, doi: 10.2147/CLEP.S40245. Coussens, A.K., Martineau, A.R., Wilkinson, R.J. (2014). Anti-inflammatory and antimicrobial actions of vitamin D in combating Tb/Hıv. Scıentıfıca. Article ID 903680, 13 pages, http://dx.doi.org/10.1155/2014/903680.
  2. Çelebi, S., Açıkk, Y., Deveci, S.E. (2004). Epidemiological features of irritable bowel syndrome in a Turkish urban society, Journal Of Gastroenterology And Hepatology, 19(7):38-43, doi: 10.1111/j.1440-1746.2004.03367.x. Drossman, D.A., Chang, L., Bellamy, N. (2001). Severity in irritable bowel syndrome: a Rome Foundation Working Team report, THE Amerıcan Journal Of Gastroenterology, 106(10):1749-1760, doi: 10.1038/ajg.2011.201. Eswaran, S., Tack, J., Chey, W.D. (2011). Food: the forgotten factor in the irritable bowel syndrome. Gastroenterology Clınıcs Of North Amerıca. 40(1):141-162, doi:10.1016/j.gtc.2010.12.012. Halmos, E.P., Power, V.A., Shepherd, S.J. (2014). A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology.146(1): 67, doi: 10.1053/j.gastro.2013.09.046. Kanazawa, M., Hongo, M., Fukudo, S. (2011) Visceral hypersensitivity in irritable bowel syndrome. Journal Of Gastroenterology And Hepatology. 26(3):119, doi: 10.1111/j.1440-1746.2011.06640.x. Karaman, N., Türkay, C., Yönem, O. (2003). Irritable bowel syndrome prevalence in city center of Sivas. THE Turkısh Journal Of Gastroenterology, 14(1):28-31, PMID: 14614640